The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Finance

Biose Industrie Raises Eur 30 Million To Strengthen Its Position As The Reference Microbiome Cdmo
Finance

Biose Industrie Raises Eur 30 Million To Strengthen Its Position As The Reference Microbiome Cdmo

JUL 20, 2020
Boost Biomes announces close of Series A and co-development agreement for biostimulants products
Finance

Boost Biomes announces close of Series A and co-development agreement for biostimulants products

JUN 29, 2020
Novozymes acquires PrecisionBiotics Group to advance its business within human health
Biotics and Supplements

Novozymes acquires PrecisionBiotics Group to advance its business within human health

JUN 26, 2020
Enterome Completes €46.3 Million Financing to Progress the Clinical Development of Its Therapeutic Pipeline
Finance

Enterome Completes €46.3 Million Financing to Progress the Clinical Development of Its Therapeutic Pipeline

JUN 25, 2020
Debiopharm’s Microbiome Remodeling Program Licensed to Takeda for the Treatment of Gastrointestinal Disorders
Finance

Debiopharm’s Microbiome Remodeling Program Licensed to Takeda for the Treatment of Gastrointestinal Disorders

JUN 10, 2020
Chr. Hansen acquires UAS Laboratories LLC to extend the microbial platform and strengthen probiotic production flexibility
Biotics and Supplements

Chr. Hansen acquires UAS Laboratories LLC to extend the microbial platform and strengthen probiotic production flexibility

JUN 9, 2020
Kaleido Biosciences Announces Proposed Public Offering of Common Stock
Finance

Kaleido Biosciences Announces Proposed Public Offering of Common Stock

JUN 2, 2020
Intralytix Receives Multimillion-Dollar Clinical Trial Award From NIAID to Manage Shigella Infections in Humans
Clinical & Manufacturing

Intralytix Receives Multimillion-Dollar Clinical Trial Award From NIAID to Manage Shigella Infections in Humans

MAY 11, 2020
Microbiome after coronavirus: Investing in the power of microbes
Editor's Choice

Microbiome after coronavirus: Investing in the power of microbes

APR 30, 2020
Chr. Hansen acquires HSO Health Care to grow probiotics offering for women’s health
Biotics and Supplements

Chr. Hansen acquires HSO Health Care to grow probiotics offering for women’s health

APR 23, 2020
Lodo Therapeutics Achieves Preclinical Milestone In Strategic Collaboration with Genentech
Finance

Lodo Therapeutics Achieves Preclinical Milestone In Strategic Collaboration with Genentech

APR 9, 2020